Prosta Zine Plus
formulated to help support prostate health
With a proprietary blend with Beta-sitasterol
Beta Sitosterol is Highly Effective in Treatin an Enlarged Prostate as well as for Lowering Cholesterol
Beta-sitosterol is phytosterol or plant alcohol that is literally in every vegetable we eat. We eat it every day but we just don't get enough of it. The typical American is estimated to eat only 200-400 mg a day while vegetarians probably eat about twice this much. This is surely one of the many reasons vegetarians are healthier and live longer. Actually the term "beta-sitosterol" in commerce refers to the natural combination of beta-sitosterol, stigmasterol, campesterol and brassicasterol as this is how they are made by nature in plants. There are no magic foods with high levels of phytosterols, but they can be inexpensively extracted from sugar cane pulp, soybeans and pine oil.
Beta Sitosterol and the Prostate
There are dozens and dozens of classic double blind studies done with real men on the effects of beta-sitosterol on benign prostate hypertrophy or BPH. Below we have summarized some of these studies . . . all of which indicate that beta-sitosterol is a highly effective trreatment for BPH.
A most unique review of 31 years of studies was published in the volume 280 of the Journal of the American Medical Association (1998 where they chose 18 different trials involving 2,939 men in total who were treated for BPH with strong extracts of saw palmetto containing beta-sitosterol. They said after reviewing all these studies, "The evidence suggests that Serenoa repens (saw palmetto) improves urologic symptoms and and flow measures."
One of the very best studies done was published in the British Journal of Urology, volume 80 (1997), at the University of Dresden. Drs. Klippel, Hilti and Schipp studied 177 men for 6 months who suffered from BPH. Half the men got a placebo and half got the prescription extract Azuprostat containing 130mg of beta-sitosterol. They cited a full 32 references to substantiate their research. They carefully screened all the men and tested them extensively during the study. They concluded, "These results show that beta-sitosterol is an effective option in the treatment of BPH."
Another unique review in a different manner was done by Dr. Buck in the British Journal of Urology, volume 78 (1996). At the Department of Urology in Glasgow, Scotland he did a 12 page review of herbal therapy for the prostate including Harzol, Tadenan, Permixon, Strogen and Sabalux (all European prescription herbal extracts standardized for beta-sitosterol content). He documents his review with 59 published worldwide studies and discusses the biological basis of prostate illness. His conclusions of the efficacy of herbal treatment of prescription drugs and therapy are well founded certainly.
In the Lancet, vol 345 (1995) a very professional study was done at the University of Bochum in Herne, Germany by Dr. Berges and his associates. They used pure beta-sitosterol with 200 men half of whom received a placebo over the course of a year. They said, "Significant improvement in symptoms and urinary flow parameters show the effectiveness of beta-sitosterol in the treatment of BPH." This is clearly one of the most important and well done studies on prostate ever published.
In volume 55 of Current Therapeutic Research (1994) a study done at the University of Brussels, Belgium by Dr. Braeckman using Prostaserene (an extract standardized for beta-sitosterol) for a mere six weeks led him to conclude, "Traditional parameters for quantifying prostatism, such as the International Prostate Symptom Score, the quality of life score, urinary flow rates, residual urinary volume, and prostate size were found to be significantly improved after only 45 days of treatment. After 90 days of treatment, a majority of patients (88%) and treating physicians (88%) considered the therapy effective."
A study published in volume 21 of European Urology (1992), at the Institute of Clinical Medicine at the University of Rome, DiSilverio and his colleagues studied 35 men with BPH for 3 months and gave half of them a placebo (inert capsules). They concluded, "On the basis of these considerations, monotherapy with S. repens extract (beta-sitosterol extracted from saw palmetto) may be more favorably accepted, since on account of similar clinical results, when compared to the combination therapy cyproterone acetate plus tamoxifen..."
In the German journal Wiener Klinische Wochenschrift, volume 22 (1990) at eight different urological clinics in Europe 263 total patients with BPH were studied over a two month period. They were given either Tadenan (a Pygeum africanum extract standardized for beta-sitosterol content) or a placebo. This very extensive study compiled from different clinics and different doctors yet all agreed that, "Treatment with the Pygeum africanum extract led to a marked clinical improvement: a comparison of the quantitative parameters showed a significant difference between the Pygeum africanum group and the placebo group with respect to therapeutic response."
Again, in Minerva Urologica e Nefrologica, volume 39 (1987), Drs. Bassi et al at the University of Padova studied 40 men with BPH with and extract of Pygeum africanum with a high beta-sitosterol content. Half the men received a placebo and many parameters were measured for the two month study. They concluded, "The preliminary results demonstrate a significant improvement of the frequency, urgency, dysuria (difficult, painful urination) and urinary flow in patients treated with the active drug."
In the Italian journal Minerva Urologica e Nefrologica, volume 37 (1985), doctors at the University of Padova studied the effect of beta-sitosterol extract on 27 men with BPH. Dr. Tasca and his associates measured urine flow and other parameters in men ranging from ages 49 to 81 compared to men receiving a placebo.
In the journal Urolage A, volume 24 (1985) at the University of Basel, Switzerland, Dr. Vontobel and his colleagues studied a strong extract of nettles containing a high concentration of beta-sitosterol in a double blind study of 50 men for nine weeks. They said that the use of beta-sitosterols from nettles, "The evaluation of the objective parameters showed significant differences."
The British Journal of Clinical Pharmacology in volume 18 (1984) at the Hospital Ambroise in Paris, Champault and two other doctors did a classic double blind study with 110 men half of them getting a placebo. They concluded, "Thus as predicted by pharmacological and biochemical studies PA109 (4 tablets of Permixon daily) would therefore appear to be a useful therapeutic tool in the treatment of BPH."
In Medical Science Research, volume 16 (1983), Drs. Malini and Vanithakumari at the Institute of Medical Sciences in Madras, India studied the effect of beta-sitosterol on the fructose concentration of the prostate. Fructose is vital to the function of the prostate with regard to the androgenic hormones such as DHEA and testosterone. This was a very unique and thorough study lasting almost two months.
In volume 77 of the German journal Midizinische Klinik (1982) a study done at the Urological Clinik of Krankenhauser in Ludenscheid-Hellersen was performed on 23 patients. Dr. Szutrely gave the patients either Harzol (herbal extract standardized for beta-sitosterol content) or a placebo for patients with prostate enlargement over a two month period. They measured their prostates with ultrasound equipment before and after treatment. At the end he said, "Within the scope of a controlled double blind study to demonstrate the effect of conservative therapy of benign prostatic hyperplasia with Harzol, ultrasonic examination of the prostate adenoma (enlargement) was carried out on 23 patients before and after therapy with the trial preparation of a placebo. Within a two month treatment with Harzol there was a significant change in echo structure of the prostate adenoma, and this is interpreted as a reduction in the interstitial formation of oedema (swelling)."
These have been only a few of the many dozens of medical journal publications of studies taken place in some of the most important urological clinics around the world. These studies all indicate that beta-sitosterol is highly effective in reducing enlarged prostates in BPH patients as well as significantly decreasing their BPH symptoms.
*The products and the claims made about specific products on or through this site have not been evaluated by Nutrition Rx, LLC or the United States Food and Drug Administration and are not approved to diagnose, treat, cure or prevent disease. The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a health care professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.